What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of study are Cancer research, Pathology, Cancer, Tumor suppressor gene and Gene.
His Cancer research research is multidisciplinary, incorporating elements of Methylation, DNA methylation, Carcinogenesis, Point mutation and Prostate cancer.
He has researched Carcinogenesis in several fields, including Cell cycle and Haematopoiesis.
His Pathology research integrates issues from Head and neck squamous-cell carcinoma, Head and neck cancer, Internal medicine and Loss of heterozygosity.
His Cancer research incorporates themes from Lung cancer and Oncology.
His Tumor suppressor gene study deals with Locus intersecting with Chromosome 9.
His most cited work include:
- p53 mutations in human cancers (6981 citations)
- A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer (3519 citations)
- Participation of p53 Protein in the Cellular Response to DNA Damage (3461 citations)
What are the main themes of his work throughout his whole career to date?
David Sidransky mainly investigates Cancer research, Cancer, Pathology, Internal medicine and DNA methylation.
His Cancer research study which covers Carcinogenesis that intersects with Gene silencing.
David Sidransky works mostly in the field of Cancer, limiting it down to topics relating to Mutation and, in certain cases, Mitochondrial DNA, as a part of the same area of interest.
His Pathology study incorporates themes from Primary tumor, Loss of heterozygosity and Adenocarcinoma.
His Internal medicine study combines topics in areas such as Endocrinology and Oncology.
His research in DNA methylation intersects with topics in Molecular biology, Methylation and Prostate cancer.
He most often published in these fields:
- Cancer research (48.23%)
- Cancer (37.97%)
- Pathology (30.00%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (48.23%)
- Cancer (37.97%)
- Head and neck squamous-cell carcinoma (15.82%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cancer research, Cancer, Head and neck squamous-cell carcinoma, Oncology and Internal medicine.
His studies in Cancer research integrate themes in fields like Cell, Cell growth, Downregulation and upregulation, microRNA and Kinase.
His Cancer study combines topics from a wide range of disciplines, such as Epigenetics, Alternative splicing and Central nervous system.
As part of one scientific family, David Sidransky deals mainly with the area of Epigenetics, narrowing it down to issues related to the DNA methylation, and often Pathology, Germline, Carcinoma and Early detection.
His Head and neck squamous-cell carcinoma research is multidisciplinary, incorporating perspectives in Metastasis, Notch signaling pathway, Mitochondrial DNA and Tissue microarray.
His Oncology research includes themes of KRAS and Proportional hazards model.
Between 2016 and 2021, his most popular works were:
- Correction: Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma (158 citations)
- Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors (105 citations)
- Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy (98 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
David Sidransky mostly deals with Cancer research, Cancer, Head and neck squamous-cell carcinoma, Lung cancer and Internal medicine.
His Cancer research research focuses on Tumor microenvironment in particular.
David Sidransky specializes in Cancer, namely Carcinogenesis.
David Sidransky has included themes like Tyrosine kinase, DNA methylation, Bioinformatics and ALK Gene Rearrangement in his Lung cancer study.
His work deals with themes such as DYRK1A, Oncology and Pathology, which intersect with Internal medicine.
David Sidransky combines subjects such as Sanger sequencing and Vaginal flora with his study of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
